Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011:2011:516042.
doi: 10.1155/2011/516042. Epub 2011 Oct 29.

Immunodiagnosis of neurocysticercosis: ways to focus on the challenge

Affiliations
Review

Immunodiagnosis of neurocysticercosis: ways to focus on the challenge

M Esquivel-Velázquez et al. J Biomed Biotechnol. 2011.

Abstract

Neurocysticercosis (NCC) is a disease of the central nervous system that is considered a public health problem in endemic areas. The definitive diagnosis of this disease is made using a combination of tools that include imaging of the brain and immunodiagnostic tests, but the facilities for performing them are usually not available in endemic areas. The immunodiagnosis of NCC is a useful tool that can provide important information on whether a patient is infected or not, but it presents many drawbacks as not all infected patients can be detected. These tests rely on purified or semipurified antigens that are sometimes difficult to prepare. Recent efforts have focused on the production of recombinant or synthetic antigens for the immunodiagnosis of NCC and interesting studies propose the use of new elements as nanobodies for diagnostic purposes. However, an immunodiagnostic test that can be considered as "gold standard" has not been developed so far. The complex nature of cysticercotic disease and the simplicity of common immunological assumptions involved explain the low scores and reproducibility of immunotests in the diagnosis of NCC. Here, the most important efforts for developing an immunodiagnostic test of NCC are listed and discussed. A more punctilious strategy based on the design of panels of confirmed positive and negative samples, the use of blind tests, and a worldwide effort is proposed in order to develop an immunodiagnostic test that can provide comparable results. The identification of a set of specific and representative antigens of T. solium and a thorough compilation of the many forms of antibody response of humans to the many forms of T. solium disease are also stressed as necessary.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Factors involved in NCC. The development of NCC depends on many factors from either the host or the parasite. The factors affecting the immune response of the host are particularly important for the immunodiagnosis of NCC as they may affect the results between individuals.

Similar articles

Cited by

References

    1. García HH, Gonzalez AE, Evans CAW, Gilman RH. Taenia solium cysticercosis. The Lancet. 2003;362(9383):547–556. - PMC - PubMed
    1. White AC. Neurocysticercosis: a major cause of neurological disease worldwide. Clinical Infectious Diseases. 1997;24(2):101–115. - PubMed
    1. World Health Organization (WHO) Control of neurocysticercosis. In: Proceedings of the 55th World Health Assembly; April 2002; Provisional Agenda Item 13.18.
    1. Colli BO, Martelli N, Júnior JAA, et al. Cysticercosis of the central nervous system. I. Surgical treatment of cerebral cysticercosis: a 23 years experience in the Hospital das Clínicas of Ribeirão Preto Medical School. Arquivos de Neuro-Psiquiatria. 1994;52(2):166–186. - PubMed
    1. Peralta RHS, Vaz AJ, Pardini A, et al. Evaluation of an antigen from Taenia crassiceps cysticercus for the serodiagnosis of neurocysticercosis. Acta Tropica. 2002;83(2):159–168. - PubMed

Publication types

Substances

LinkOut - more resources